Edwards Lifesciences
Clinical trials sponsored by Edwards Lifesciences, explained in plain language.
-
Growing heart valve could spare kids multiple surgeries
Disease control Not yet recruitingThis study tests a special heart valve that can be adjusted to fit children as they grow. It involves 36 kids aged 1.5 to 16 years with congenital heart disease who need a new pulmonary valve. The valve is placed during surgery and can later be expanded without another operation.
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New heart valve aims to improve tricuspid replacement outcomes
Disease control Not yet recruitingThis study is testing a new artificial heart valve, called the TRIFORMIS RESILIA, for people who need their tricuspid valve replaced. The tricuspid valve controls blood flow between two right heart chambers. Researchers will follow 75 adults who receive this valve during surgery …
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New heart valve offers hope for High-Risk patients
Disease control Not yet recruitingThis study tests a new heart valve (SAPIEN X4) in 125 people with mitral valve disease who are too high-risk for open-heart surgery. The valve is placed using a thin tube through a blood vessel, avoiding major surgery. The goal is to see if the valve is safe and improves heart fu…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC